Finnrick
Independent peptide-testing and vendor-trust publisher that overlaps directly with PeptideBenchmark's review ecosystem and makes a large volume of public testing data visible.
Readers who want an independent publisher / testing-platform-style reference point rather than a classic lab profile.
Finnrick is useful as an external signal layer, but it should not be treated as a substitute for vendor-linked batch documentation.
This label reflects how the provider presents itself on its own site today, not a formal accreditation category.
Whether the site appears to invite direct sample submission from individuals rather than only business or institutional clients.
Whether the provider appears to offer public-facing report publishing, result browsing, or direct verification tooling.
This is our shorthand for how visible the provider's result or verification layer appears to be, ranging from none to searchable public verification.
Location details are kept conservative and only shown when clearly supported by the source page or the provider’s public materials.
This provider is part of the current testing-provider comparison layer because it anchors a meaningful part of the vendor transparency graph, not just because it has a standalone profile.
Readers who want an independent publisher / testing-platform-style reference point rather than a classic lab profile.
Finnrick is useful as an external signal layer, but it should not be treated as a substitute for vendor-linked batch documentation.
This role matters because it creates broad public visibility around testing and vendor trust, even when it does not look like a classic lab intake or verification portal.
- Use public-library providers as an external visibility layer, not as a substitute for vendor-linked batch documentation.
- They are most valuable when they corroborate or complicate vendor-side evidence rather than replace it.
- The main distinction is breadth of public testing visibility, not direct control over every linked vendor certificate surface.
What we can verify now
Finnrick does not fit neatly into a plain lab-directory model.
It makes more sense to classify it as an Independent Publisher because the value it provides is tied to public testing coverage and transparency rather than just offering generic lab intake.
The homepage currently states that Finnrick has tested thousands of samples across hundreds of vendors and dozens of peptide categories, which makes it one of the most visible public testing-data publishers in this niche.
Why it belongs here
This directory is intentionally broader than “labs only” because the peptide-testing ecosystem includes:
- analytical labs
- testing/report platforms
- and independent publishers that make testing visible
Why it matters in the current vendor graph
Finnrick matters because it is one of the clearest examples of an independent publisher layer sitting adjacent to labs and vendor-run COA systems.
That makes it useful for readers who want:
- broad public testing visibility across many vendors
- a publisher-style reference point for external sample coverage
- and a separate signal layer that can sometimes corroborate or complicate a vendor’s own COA story
What to watch for
Finnrick is still a different evidence type from vendor-linked batch documentation.
It can strengthen or weaken confidence around a vendor over time, but readers should not treat publisher coverage alone as a substitute for:
- product-level public reports
- public verification pages
- or named outside-lab documentation tied to specific batches
Coverage notes
- Finnrick is especially important for future vendor-to-testing linkage because it already overlaps with PeptideBenchmark’s vendor ranking environment